The authors contend that sEVs’ Aβ42, T-tau, and P-T181-tau have the capacity to diagnose AD similar to those present in CSF since there was a high correlation between sEVs biomarkers in the blood and CSF [56]. This evidence concerns the gene MAPT and Alzheimer disease.